Q1 2018 Earnings Presentation

GROUP OVERVIEW: Q1 2018 Operating Performance CARE www. min Inovation wi CARE of you Ascend 400 BRUKER Bruker BIOSPIN Group BIOSPIN revenue modestly below prior year in constant currency due to NMR revenue timing ■ Applied & clinical research systems revenue higher PCI systems recovery ongoing ▪ After-market service revenue continues to grow ■ ■ BRUKER Bruker CALID Group CALID high-single digit constant currency revenue growth ▪ Daltonics revenue higher with strong performance in microbiology markets and healthy growth in life science mass spec ■ ■ Optics revenue grows with good execution and healthy industrial, applied and academic demand ▪ Detection revenue lower year-over-year 91 5

View entire presentation